The importance of body composition assessment for patients with advanced hepatocellular carcinoma by bioelectrical impedance analysis in lenvatinib treatment.

导出 OA

翻译打印收藏纠错

第一作者： Kenji,Yamaoka

第一单位： Department of Gastroenterology and Metabolism, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.;Research Center for Hepatology and Gastroenterology, Hiroshima University, Hiroshima, Japan.

作者： Kenji,Yamaoka ^[1] ; Kenichiro,Kodama ^[1] ; Tomokazu,Kawaoka ^[1] ; Masanari,Kosaka ^[1] ; Yusuke,Johira ^[1] ; Yuki,Shirane ^[1] ; Ryoichi,Miura ^[1] ; Shigeki,Yano ^[1] ; Serami,Murakami ^[1] ; Kei,Amioka ^[1] ; Kensuke,Naruto ^[1] ; Yuwa,Ando ^[1] ; Yumi,Kosaka ^[1] ; Shinsuke,Uchikawa ^[1] ; Takuro,Uchida ^[1] ; Hatsue,Fujino ^[1] ; Takashi,Nakahara ^[1] ; Eisuke,Murakami ^[1] ; Wataru,Okamoto ^[2] ; Masami,Yamauchi ^[1] ; Daiki,Miki ^[1] ; Michio,Imamura ^[1] ; Shoichi,Takahashi ^[1] ; Akiko,Nagao ^[3] ; Kazuaki,Chayama ^[4] ; Hiroshi,Aikata ^[1]

作者单位： Department of Gastroenterology and Metabolism, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.;Research Center for Hepatology and Gastroenterology, Hiroshima University, Hiroshima, Japan. ^[1] Cancer Treatment Center, Hiroshima University Hospital, Hiroshima, Japan. ^[2] Division of Nutrition Management, Hiroshima University, Japan. ^[3] Research Center for Hepatology and Gastroenterology, Hiroshima University, Hiroshima, Japan.;Collaborative Research Laboratory of Medical Innovation, Hiroshima University, Hiroshima, Japan.;RIKEN Center for Integrative Medical Sciences, Kanagawa, Japan. ^[4]